A note on age-related comorbidity

Archives of Gerontology and Geriatrics

Volumn 49, Issue 1, 2009, Pages 93-97

  Weale, Robert A ^a,b  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON HOSPITALS   (United Kingdom)

Author keywords

Age related prevalence; Elimination of the variable of age; Partial correlation

Indexed keywords

AGING; ARTICLE; COMORBIDITY; DISEASE CLASSIFICATION; HUMAN; PREVALENCE; PRIORITY JOURNAL;

AGED; COMORBIDITY; DEMENTIA; HUMANS; MACULAR DEGENERATION; PREVALENCE; PROSPECTIVE STUDIES;

EID: 67349185926     PISSN: 01674943     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.archger.2008.05.010     Document Type: Article

References (62)

1. AIHW Analysis of Australian Bureau of Statistics 2001, National Health Survey, Australia.
2. Allanore Y., Parc C., Monnet D., Brézin A.P., and Kahan A. Increased prevalence of ocular glaucomatous abnormalities in systemic sclerosis. Ann. Rheum. Dis. 63 (2004) 1276-1278
3. Antonicelli R., Gesuita R., and Paciaroni E. Sexual dimorphism in arterial hypertension: an age-related phenomenon. Arch. Gerontol. Geriatr. 29 (2000) 283-289
4. Belzunce A., and Casellas M. Vascular risk factors in primary angle glaucoma. Anal. Sist. Sanit. Navar. 27 (2004) 335-344
5. Bonfils P., Halimi P., and Malinvaud D. Adrenal suppression and osteo-porosis after treatment of nasal polyposis. Acta Oto-Laryngol. 126 (2006) 1195-1200
6. Boyd C.M., Weiss C.O., Halter J., Han K.C., Ershler W.B., and Fried L.P. Framework for evaluating disease severity measures in older adults with comorbidity. J. Gerontol. A, Biol. Sci. Med. Sci. 62A (2007) M286-M295
7. Burton M., Fergusson E., Hart A., Knight K., Lary D., and Liu C. The pre-valence of cataract in two villages of northern Pakistan with different levels of ultraviolet radiation. Eye 11 (1997) 95-101
8. Cedrone C., Culasso F., Cesareo M., Mancino R., Ricci F., Cupo G., and Cerulli L. Prevalence and incidence of age-related cataract in a population from Priverno, Italy. Ophthal. Epidemiol. 6 (1999) 95-103
9. Chen L.-K. Cataract surgery after acute stroke: maybe more than a coincidence. Stroke 37 (2006) 766
10. Cherayil G.D. Fatty acid composition of brain glycolipids in Alzheimer's disease, senile dementia, and cerebrocortical atrophy. J. Lipid Res. 9 (1968) 207-214
11. Collignon N., Dewe W., Guillaume S., and Collignon-Brach J. Ambulatory blood pressure monitoring glaucoma patients. The nocturnal systolic dip and its relationship with disease progression. Internat. Ophthalmol. 22 (1998) 19-25
12. Comfort A. Test battery to measure aging rate in man. The Lancet ii (1969) 1411-1415
13. Curb J.D., Abbott R.D., MacLean C.J., Rodriguez B.L., Burchfiel C.M., Sharp D.S., Ross G.W., and Yano K. Age-related changes in stroke risk in men with hypertension and normal blood pressure. Stroke 27 (1996) 819-824
14. Dadoni L.G., Corral J., and Gadda C. Osteoporosis, with pathological fracture and cataract, caused by chronic corticotherapy. Prensa Med. Argent. 59 (1972) 786-787
15. Dam H., Harhoff M., Anderen P.K., and Kessing L.V. Increased risk of treatment with antidepressants in stroke with other chronic illness. Intern. Clin. Psychopharm. 22 (2007) 13-19
16. DeKorte C.J. Current and emerging therapies for the management of chronic inflammation of asthma. Am. J. Health-Syst. Pharm. 60 (2003) 1949-1959
17. De Voogd S., Wolfs R.C.W., Jansonius N.M., Witteman J.C.M., Hofman A., and De Jong P.T.V.M. Atherosclerosis, C-reactive protein, and risk for open-angle glaucoma: the Rotterdam study. Invest. Ophthalmol. Vis. Sci. 47 (2006) 3772-3776
18. Dhillon T., and Waxman J. Osteoporosis and prostate cancer. Brit. J. Cancer. 89 (2003) 779-780
19. Fratiglioni L., Grut M., Forsell Y., Viitanen M., Grafström M., Holmén K., Ericsson K., Bäckman L., Ahlbom A., and Winblad B. Prevalence of Alzheimer's and other dementias in an elderly urban population: relationship with age, sex, and education. Neurology 41 (1991) 1886-1892
20. Glezos S.P. Taste and smell loss: risk for disease?. The NIH Rec. 49 (1997) 1-2
21. Hays W.L. Statistics for the Social Sciences. second ed. (1976), Holt, Rinehart and Winston, London p. 711
22. Heckmann J.G., Stossel C., Lang C.J., Neundorfer B., Tomandl B., and Hummel T. Taste disorders in acute stroke: a prospective observational study on taste disorders in 102 stroke patients. Stroke 36 (2005) 1690-1694
23. Hofman A., Breteler M.M., Bots M.L., Slooter A.J., Van Harskamp F., Van Duijn C.N., Van Broeckhoven C., and Grobbee D.E. Atherosclerosis, apoliprotein E, and prevalence of dementia and Alzheimer's disease in the Rotterdam study. The Lancet 349 (1997) 1174
24. Holliday R. The close relationship between biological aging and age-associated pathologies in humans. J. Gerontol. A, Biol. Sci. Med. Sci. 59 (2004) B543-B546
25. Hu F.B., Hankinson S.E., Stampfer M.J., Manosn J.E., Collditz G.A., Speizer F.E., Hennekens C.H., and Willett W.C. Prospective study of cataract extraction and risk of coronary heart disease in women. Am. J. Epidemiol. 153 (2001) 875-881
26. Iseri P.K., Altinas O., Tokay T., and Yuksel N. Relationship between cognitive impairment and retinal morphological and visual functional abnormalities in Alzheimer disease. J. Neuro-Ophthal. 1 (2006) 18-24
27. ITP Treatment, April 2005. The Oklahoma ITP Registry Newsletter.
28. Jeppesen B.B. Greenland, a soft-water area with a low incidence of ischemic heart death. Magnesium 6 (1987) 307-313
29. Jonasson F., and Thordarson K. Prevalence of ocular disease and blindness in a rural area in the Eastern region of Iceland during 1980 through 1984. Acta Ophthalmol. Suppl. 182 (1987) 40-43
30. Jonasson F., Arnarsson A., Sasaki H., Peto T., Sasaki K., and Bird A.C. The prevalence of age-related maculopathy in Iceland Reykjavik Eye Study. Arch. Ophthal. 121 (2003) 379-385
31. Klaver C.C.W., Kliffen M., Van Duijn C., Hofman A., Cruts M., Grobbee D.E., Van Broeckhoven C., and De Jong P.T.V.M. Genetic association of apolipo-protein E with age-related macular degeneration. Am. J. Hum. Genet. 63 (1998) 200-206
32. Klaver C.C.W., Ott A., Hofman A., Assink J.J., Breteler M.M., and De Jong P.T. Is age-related maculopahy associated with Alzheimer's disease? The Rotterdam study. Am. J. Epidemiol. 150 (1999) 963-968
33. Klein R., Klein B.E.K., and Linton K.L.P. Prevalence of age-related maculopathy. The Beaver Dam eye study. Ophthalmology 99 (1992) 933-934
34. Klein R., Clegg L., Cooper L.S., Hubbard L.D., Klein B.E.K., King W.N., and Folsom A.R. Prevalence of age-related maculopathy in the Atherosclerosis risk in communities study. Arch. Ophthal. 117 (1999) 1203-1210
35. Klein B.E.K., Klein R., Lee K.E., Moore E.L., and Danforth L. Risk of incident age-related eye diseases in people with an affected sibling: the Beaver Dam Eye Study. Am. J. Epidemiol. 154 (2001) 207-211
36. Laatikainen L., and Hirvela H. Prevalence and visual consequences of macular changes in a population aged 70 years and older. Acta. Ophthalmol. Scand. 73 (1995) 105-110
37. Langman M.J.S., Lancashire R.J., Cheng K.K., and Stewart P.M. Systemic hypertension and glaucoma: mechanisms in common and co-occurrence. Brit. J. Ophthalmol. 89 (2005) 960-963
38. Lee A.J., Wang J.J., Kifley A., and Mitchell P. Open-angle glaucoma and cardiovascular mortality. Ophthalmology 113 (2006) 1069-1076
39. Liew G., and Mitchell P. Ranibizumab for neovascular age-related macular degeneration. N. Engl. J. Med. 356 (2007) 747-750
40. Lobo A., Launer L.J., Fratiglioni L., Andersen K., Di Carlo A., Breteler M.M.B., Copeland J.R.M., Dartigues J.-F., Jagger C., Martinez-Lage J., Soininen H., and Hofman A. Prevalence of dementia and major subtypes in Europe: a collaborative study of population-based cohorts. Neurology 54 (2000) S4-S9
41. Marcovitz P.A., Tran H.H., Franklin B.A., O'Neill W.W., Yerkey M., Boura J., Kleerekoper M., and Dickinson C.Z. Usefulness of bone mineral density to predict significant coronary artery disease. Am. J. Cardiol. 96 (2005) 1059-1063
42. Masud, T., Taylor, R., Pearson, D., Mohammed, M., 2003. Risk factors for the diagnosis of osteoporosis in women using heel pDXA. The Nottingham Community Osteoporosis (NOCOS) study. Power-Point Presentation. Internet.
43. McCarty C.A., Mukesh B.N., Fu C.L., and Taylor H.R. The epidemiology of cataract in Australia. Am. J. Ophthalmol. 128 (1999) 4464-4465
44. McGill Jr. H.C., McMahan C.A., Malcom G.T., Oalmann M.C., Strong J.P., and For the PDAY Research Group. Effects of serum lipoproteins and smoking on atherosclerosis in young men and women. Arterioscl. Thromb. Vasc. Biol. 17 (1997) 95-106
45. Mitchell P., Smith W., Attebo K., and Wang J.J. Prevalence of age-related maculopathy in Australia. The Blue Mountains study. Ophthalmology 102 (1995) 1450-1460
46. Mitchell P., Cummings R.G., Attebo K., and Panchapakesan J. Prevalence of cataract in Australia: the Blue Mountains eye study. Ophthalmology 104 (1997) 581-588
47. Nakamura E. A study on the basic nature of human biological aging processes based upon a hierarchical factor solution of the age-related physiological variables. Mech. Ageing Devel. 60 (1991) 153-170
48. Oshima Y., Ishibashi T., Murata T., Tahara Y., Kiyohara Y., and Kubota T. Prevalence of age-related maculopathy in a representative Japanese population: the Hisayana Study. Brit. J. Ophthalmol. 85 (2001) 153-157
49. Ravussin E., and Bouchard C. Human genomics and obesity. Eur. J. Pharm. 410 (2000) 131-145
50. Robertson G.W., and Yudkin J. Effect of age upon dark adaptation. J. Physiol. 103 (1944) 1-8
51. Schachat A.P., Hyman L., Leske C., Connell A.M.S., Wu S.Y., and Barbados Eye Study Group. Features of age-related macular degeneration in a black population. Arch. Ophthalmol. 113 (1995) 728-735
52. Schiffman S.S. Diagnosis and treatment of smell and taste disorders. West J. Med. 146 (1987) 471-473
53. Seitzman R.L., Mangione C.M., Cauley J.A., Ensrud K.E., Stone K.L., Cummings S.R., Hochberg M.C., Hillier T.A., Yu F., and Coleman A.L. Bone mineral density and age-related maculopathy in older women. J. Am. Geriatr. Soc. 55 (2007) 740-746
54. Smith G.D. The biopsychosocial approach: a note of caution. In: White P. (Ed). Biopsychosocial Medicine (2005), Oxford University Press, Oxford 77-98
55. Tanaka H., Dinenno F.A., Monahan K.D., DeSouza C.A., and Seals D.R. Carotid artery wall hypertrophy with age is related to local systolic blood pressure in healthy men. Arterioscl. Thromb. Vasc. Biol. 21 (2001) 82
56. Tanvetyanon T. Physician practices of bone density testing and drug pre-scribing to prevent or treat osteoporosis during androgen deprivation therapy. Cancer 103 (2005) 237-241
57. Varma R., Ying-Lai M., Klein R., Azen S.P., and Los Angeles Latino Eye Study Group. Prevalence and risk indicators of visual impairment and blindness in Latinos: the Los Angeles Latino Eye Study. Ophthalmology 111 (2004) 1132-1140
58. Vinding T. Age-related macular degeneration. Acta Ophthalmol. 67 (1989) 609-616
59. Vingerling J.H., Dielemans I., Bots M.L., Hofman A., Grobbee D.E., and De Jong P.T.V.M. Age-related macular degeneration is associated with atherosclerosis. Am. J. Epidemiol. 142 (1995) 404-409
60. Wachter A., Sun Y., Dasch B., Krause K., Pauleikhoff D., Hense H.W., and Munster Age- and Retina Study (MARS). Association between risk factors for arteriosclerosis and age-related macular degeneration. Ophthalmologie 101 (2004) 50-53
61. Wang J.J., Mitchell P., Cumming R.G., and Lim R. Cataract and age-related maculopathy: the Blue Mountains Eye Study. Ophthalmol. Epidemiol. 6 (1999) 317-326
62. Weale R.A. The eye within the framework of human senescence: biological decline and mortality. Ophthalmic Res. 30 (1998) 59-73